Andrea Tan
Stock Analyst at Goldman Sachs
(0.98)
# 3,744
Out of 4,906 analysts
46
Total ratings
38.89%
Success rate
-12.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $100 → $112 | $102.78 | +8.97% | 10 | Jun 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.49 | +221.29% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $42.18 | +20.91% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.40 | +321.88% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $8.83 | -32.05% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $14.71 | +110.74% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.61 | +225.73% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $5.08 | -60.63% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $147.72 | +8.31% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $5.15 | +366.02% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.15 | +247.83% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $330.94 | +13.31% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $10.93 | +18.94% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $2.05 | +95.12% | 2 | May 24, 2022 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $100 → $112
Current: $102.78
Upside: +8.97%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.49
Upside: +221.29%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $42.18
Upside: +20.91%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.40
Upside: +321.88%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $8.83
Upside: -32.05%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $14.71
Upside: +110.74%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.61
Upside: +225.73%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $5.08
Upside: -60.63%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $147.72
Upside: +8.31%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $5.15
Upside: +366.02%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.15
Upside: +247.83%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $330.94
Upside: +13.31%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $10.93
Upside: +18.94%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $2.05
Upside: +95.12%